Canada markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.93+0.72 (+1.84%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 51.7B
Enterprise Value 31.29B
Trailing P/E N/A
Forward P/E 1-7.33
PEG Ratio (5 yr expected) 1-4.41
Price/Sales (ttm)10.98
Price/Book (mrq)3.96
Enterprise Value/Revenue 38.37
Enterprise Value/EBITDA 6-11.68

Trading Information

Stock Price History

Beta (5Y Monthly) 1.20
52-Week Change 39.89%
S&P500 52-Week Change 337.21%
52 Week High 350.26
52 Week Low 320.03
50-Day Moving Average 343.74
200-Day Moving Average 336.56

Share Statistics

Avg Vol (3 month) 3506.57k
Avg Vol (10 day) 3341.57k
Shares Outstanding 542.5M
Float 36.95M
% Held by Insiders 114.54%
% Held by Institutions 189.90%
Shares Short (Feb. 11, 2021) 42.66M
Short Ratio (Feb. 11, 2021) 46.15
Short % of Float (Feb. 11, 2021) 49.30%
Short % of Shares Outstanding (Feb. 11, 2021) 46.27%
Shares Short (prior month Jan. 14, 2021) 42.45M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin -71.97%
Operating Margin (ttm)-77.14%

Management Effectiveness

Return on Assets (ttm)-12.36%
Return on Equity (ttm)-26.87%

Income Statement

Revenue (ttm)154.57M
Revenue Per Share (ttm)4.15
Quarterly Revenue Growth (yoy)82.20%
Gross Profit (ttm)-47.44M
EBITDA -110.83M
Net Income Avi to Common (ttm)-111.25M
Diluted EPS (ttm)-2.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)475.74M
Total Cash Per Share (mrq)11.19
Total Debt (mrq)72.65M
Total Debt/Equity (mrq)19.23
Current Ratio (mrq)6.52
Book Value Per Share (mrq)10.08

Cash Flow Statement

Operating Cash Flow (ttm)-54.06M
Levered Free Cash Flow (ttm)-20.46M